Tag Archives: TB-500

Product Pillars, Peptide Education, Research Protocols

TB-500: Complete Research Guide to Thymosin Beta-4 Peptide

Posted on by admin
TB-500
22
May

Research Use Only Notice: TB-500 is a research peptide intended for in-vitro and animal research applications only. It is not FDA-approved as a drug or therapy. Nothing in this article constitutes medical advice, treatment recommendation, or guidance for human consumption.

TB-500 is the synthetic peptide version of thymosin beta-4 — a naturally occurring 43-amino-acid peptide found throughout human and animal tissues. Research on TB-500 spans cardiac repair, dermal wound healing, corneal injury, and broader cell migration biology. The compound has been a focal point of tissue-repair research for decades, with substantial published literature documenting its actin-binding mechanism and downstream effects. This complete guide from the chemistry team at OPS Peptide Science walks through what TB-500 is, how it works in research models, where it sits in the broader research catalog, and how it pairs with BPC-157 in combination protocols.

For the foundational research-workflow protocols this guide assumes, see our companion guides on how to reconstitute peptides, how to inject peptides, and peptide storage and refrigeration.

What Is TB-500?

TB-500 is the synthetic, research-grade version of thymosin beta-4 (TB-4) — a 43-amino-acid peptide naturally produced in nearly all human and animal tissues. The “500” designation refers to the research nomenclature, not a fragment number — TB-500 is the full-length thymosin beta-4 sequence, synthesized for laboratory use.

Key facts about TB-500:

  • Chemical class — 43-amino-acid peptide, synthetic version of naturally occurring thymosin beta-4
  • Molecular weight — approximately 4963 Da
  • Source — synthesized to match the natural human thymosin beta-4 sequence
  • Form — typically supplied as lyophilized (freeze-dried) powder; reconstituted with bacteriostatic water for research administration
  • Half-life — longer than most small peptides due to tissue binding; effective biological half-life is measured in days rather than hours
  • Stability — stable at -20°C as lyophilized powder for 18-24 months; reconstituted solutions stable for 21-28 days refrigerated

Unlike many research peptides, TB-500’s natural counterpart (thymosin beta-4) is one of the most abundant peptides in mammalian cells, present at high concentrations in platelets, tissues, and circulating plasma. This means TB-500 research has a robust foundation in the natural biology of the compound — researchers know what the molecule does because cells use it for actin regulation and repair as a normal function.

TB-500

TB-500 Structure and Chemistry

The TB-500 / thymosin beta-4 sequence is one of the most characterized small peptides in cell biology research. Key structural features:

  • 43 amino acids — longer than most synthetic research peptides, which sit in the 5-15 amino acid range
  • Actin-binding domain — the central functional region that gives the peptide its primary biological activity
  • N-terminal acetylation — naturally occurring in human thymosin beta-4; synthetic TB-500 typically reproduces this modification for stability
  • Highly conserved across species — the thymosin beta-4 sequence is nearly identical across mammals, supporting cross-species research translation

The actin-binding domain is what makes TB-500 functionally interesting — it’s not a hormone analog targeting a single receptor, but a cytoskeletal modulator influencing cell shape, migration, and tissue organization at the structural level.

How TB-500 Works in Research (Mechanism)

The TB-500 mechanism is among the better-characterized of research peptides. Documented activities:

  • G-actin sequestration — TB-500 binds free G-actin monomers, regulating the dynamic balance between G-actin and F-actin (filamentous actin)
  • Actin polymerization control — by controlling G-actin availability, TB-500 influences when and where actin filaments form, which determines cell shape and movement
  • Cell migration regulation — fundamental to tissue repair, where cells must migrate to injury sites
  • Anti-inflammatory effects — independent of actin binding, TB-500 has been documented to modulate inflammatory pathways
  • Angiogenesis support — research has measured effects on endothelial cell migration and new blood vessel formation
  • Stem cell activation — published research documents effects on progenitor cell activity in repair contexts

The actin biology mechanism is what gives TB-500 its broad research applications. Almost any tissue repair process involves cell migration, and cell migration requires actin reorganization — which TB-500 directly influences. The thymosin beta-4 tissue repair literature on PubMed documents the mechanism across hundreds of studies.

TB-500 Research Applications

The research literature on TB-500 covers several major application areas:

Cardiac Research

One of the most extensively studied TB-500 applications is in cardiac injury research. Animal models of myocardial infarction have documented measurable effects on cardiac tissue repair, reduced scar tissue formation, and improved heart function endpoints in TB-500-treated subjects. This research extended to clinical trials in some countries (though TB-500 remains non-FDA-approved in the US).

Dermal Wound Healing Research

Skin injury models — burn, surgical wound, diabetic ulcer — show accelerated re-epithelialization, improved granulation tissue quality, and reduced scarring in TB-500-treated research subjects. The compound’s effects on cell migration directly support the wound-healing process at the cellular level.

Corneal Research

Ocular research includes corneal wound healing models, dry eye research, and corneal epithelial regeneration studies. TB-500 has documented effects on corneal repair markers across multiple animal research models.

Musculoskeletal Research

Tendon, ligament, and muscle injury research uses TB-500 to study cell migration during repair. The published research overlaps with BPC-157 research in this area, though the mechanisms are distinct — BPC-157 works through VEGF and angiogenesis, TB-500 works through actin and cell migration.

TB-500

Hair Follicle Research

A smaller but documented research area on TB-500 effects on hair follicle stem cells and follicle activity. Animal models have measured changes in follicle cycling and stem cell markers.

TB-500 Dosing in Research Models

TB-500 dosing in published research models has distinct features compared to shorter peptides:

  • Less frequent dosing — TB-500’s effective biological half-life supports less frequent administration than short-half-life peptides; twice-weekly or weekly protocols appear in published research
  • Larger absolute dose ranges — because the peptide is larger (43 aa vs. 15 aa for BPC-157), research doses tend to be larger in mg amounts
  • Subcutaneous or intramuscular — both routes documented in published research; SC is more common
  • Tissue depot effects — TB-500 binds tissues and produces effects beyond what acute plasma levels would predict, complicating simple pharmacokinetic interpretations

Research protocols should reference published methodology for the specific research model. Tissue-binding behavior means TB-500 dosing protocols require careful design — single doses can produce extended effects, while frequent dosing may not produce proportional additive responses.

TB-500 Storage and Stability

TB-500 stability profile aligns with most lyophilized research peptides:

Storage ConditionFormStability Window
-80°C (ultra-low freezer)Lyophilized powder3-5+ years
-20°C (standard lab freezer)Lyophilized powder18-24 months
2-8°C (refrigerated)Lyophilized powder6-12 months
Room temperatureLyophilized powder2-4 weeks for transit
2-8°C (refrigerated)Reconstituted in BAC water21-28 days

For practical storage protocols, see our companion guide on how long do peptides last at room temperature. Larger peptides like TB-500 (vs. smaller compounds like BPC-157) sometimes show slightly different oxidation susceptibility — protocols that work for both compounds generally cover TB-500 safely.

TB-500 + BPC-157 Combination Research (Wolverine Stack)

One of the most-discussed research applications is the combination of TB-500 with BPC-157 — popularly called the Wolverine Stack in research and biohacking discussions. The rationale:

  • Different mechanisms — TB-500 acts on actin and cell migration; BPC-157 acts on VEGF, angiogenesis, and multiple signaling pathways
  • Different half-lives — TB-500’s tissue-binding gives extended effects; BPC-157’s shorter half-life allows acute signaling
  • Potentially complementary — TB-500 supports the cell migration phase of repair; BPC-157 supports the angiogenesis and inflammation modulation phases
  • Documented in published research — both compounds appear in combination protocols across animal tissue-repair studies

Research design for combination studies requires separate reconstitution, alternating injection sites, and careful documentation of each compound’s contribution to the endpoint. The Wolverine Stack name is informal — published research literature uses BPC-157 + TB-500 terminology — but the combination protocol is real and documented. See our overview on peptides for healing and recovery for the broader context.

How to Identify Quality TB-500

TB-500’s larger size (43 amino acids vs. 15 for BPC-157) makes it more challenging to synthesize cleanly. Quality criteria for research-grade TB-500:

  • 99%+ purity confirmed by HPLC-MS analysis — synthesis of longer peptides produces more degradation products; purity verification is especially important
  • Per-lot Certificate of Analysis — each batch independently tested with full chromatographic profile
  • Mass spectrometry identity confirmation — confirms the molecular weight matches TB-500 (4963 Da), distinguishing from shorter degradation products
  • Chain-of-custody documentation — traceable from manufacturer through fulfillment
  • Properly lyophilized appearance — clean white cake at the bottom of the vial, no discoloration or moisture damage
  • Research-use-only labeling — required by US regulations

At OPS Peptide Science, every TB-500 vial ships with a unique BIOVIRIDIAN COA code. Customers can verify the Certificate of Analysis for their specific lot — confirming the full HPLC-MS purity report and identity verification before opening the vial.

TB-500

TB-500 Regulatory Status

TB-500 / thymosin beta-4 occupies a specific position in US regulatory frameworks:

  • Not FDA-approved — has not completed clinical trials required for human drug approval in the US
  • WADA-prohibited — listed under category S2 (peptide hormones, growth factors, related substances), banned in and out of athletic competition
  • Legal as research chemical — sold in the US for in-vitro and animal research under research-use-only labeling
  • Not DEA-scheduled — no controlled substance status
  • Some clinical research history — has been studied in clinical trials internationally for cardiac and dermal indications, though not FDA-approved

For the complete legal framework around research peptides like TB-500, see our detailed guide on are peptides illegal. According to NIH research literature, TB-500 remains an active pre-clinical research compound across multiple tissue-repair applications.

FAQ

What is TB-500?

TB-500 is the synthetic, research-grade version of thymosin beta-4 — a 43-amino-acid peptide naturally produced in nearly all human and animal tissues. It is one of the most-studied tissue-repair research peptides, with substantial published literature documenting effects on cardiac, dermal, corneal, and musculoskeletal injury models.

Is TB-500 the same as thymosin beta-4?

Yes — TB-500 is the synthetic research-grade version of thymosin beta-4. The two names refer to the same compound, with “TB-500” being the research nomenclature and “thymosin beta-4” being the biological name. Some sources also use “TB4” as a shorthand.

Is TB-500 legal in the US?

TB-500 is legally sold in the US as a research chemical for in-vitro and animal research, under research-use-only labeling. It is not FDA-approved for human use. WADA has prohibited it in athletic competition.

How long does TB-500 stay in the body in research?

TB-500’s plasma half-life is short, but its biological half-life is much longer due to tissue binding. Effective effects in research models can extend for several days after a single dose — longer than the plasma half-life would suggest. This is why TB-500 research protocols often use less frequent dosing (twice-weekly or weekly) than shorter peptides.

What’s the difference between BPC-157 and TB-500?

Both are tissue-repair research peptides, but they act through different mechanisms. BPC-157 (15 amino acids) acts on VEGF, angiogenesis, and multiple signaling pathways. TB-500 (43 amino acids) acts on actin sequestration and cell migration. They are often combined in research protocols (the Wolverine Stack) because the mechanisms complement rather than overlap.

How is TB-500 administered in research?

Most published TB-500 research uses subcutaneous injection. Intramuscular injection also appears in some research protocols. Less frequent dosing schedules (twice-weekly or weekly) are common due to TB-500’s tissue-binding properties and extended biological half-life. See our complete guide on how are peptides administered for context across administration routes.

Where can I buy research-grade TB-500?

Research-grade TB-500 is sold by research peptide suppliers operating under research-use-only labeling. Quality criteria include 99%+ HPLC-MS verified purity, per-lot Certificates of Analysis, mass spectrometry identity confirmation, and traceable chain-of-custody. Browse the OPS Peptide Science catalog for verified research-grade TB-500.

TB-500 (thymosin beta-4) stands out among research peptides for its mechanistic clarity, its broad tissue-repair research applications, and its strong pairing with BPC-157 in combination protocols. For researchers studying tissue repair, cell migration, cardiac biology, or dermal endpoints, TB-500 is one of the most-cited compounds in the modern research catalog.

For research-grade TB-500 backed by per-lot Certificates of Analysis and full HPLC-MS purity documentation, browse the OPS Peptide Science catalog, visit the OPS Peptide Science homepage for the full product overview, or verify a specific lot using its COA code.

Author: Shane Straight, Principal Chemist, OPS Peptide Science
Reviewed: May 2026

Research Protocols, Peptide Education

How to Reconstitute Peptides: Step-by-Step Research Guide

Posted on by admin
How to Reconstitute Peptides: Step-by-Step Research Guide
19
May

Research Use Only Notice: The information below describes laboratory reconstitution procedures for research-grade peptides. All compounds discussed are intended for in-vitro and animal research applications only. Nothing in this guide constitutes medical advice or instructions for human administration.

If you’ve just received a vial of lyophilized peptide and you’re staring at the powder wondering what’s next, you’re in the right place. Learning how to reconstitute peptides correctly is the single most important skill in any peptide research workflow — get it wrong and you compromise the entire experiment. This guide walks through the exact protocol our chemistry team at OPS Peptide Science uses to prepare research compounds for storage and laboratory study.

By the end, you’ll know exactly which diluent to choose, how much to add, how to handle the vial without denaturing the compound, and how long the reconstituted solution remains stable.

What Does It Mean to Reconstitute a Peptide?

Peptides shipped from a research supplier arrive in a lyophilized (freeze-dried) form. Freeze-drying removes water from the compound, leaving behind a stable, powdery cake at the bottom of the vial. This dramatically extends shelf life — a properly lyophilized peptide stored at -20°C can remain stable for 18 to 24 months.

Reconstitution is the process of adding a sterile diluent back into the vial to dissolve the powder into a usable liquid solution. Once reconstituted, the compound is ready for accurate volumetric measurement in research applications.

The diluent of choice is almost always bacteriostatic water (also called BAC water), which contains 0.9% benzyl alcohol — a preservative that prevents microbial growth in the solution. This is what allows the reconstituted peptide to be stored under refrigeration for up to 28 days. Plain sterile water can be used but offers no antimicrobial protection.

Researcher reconstituting a lyophilized peptide vial with bacteriostatic water using a sterile syringe

What You Need Before You Begin

A clean reconstitution requires a small but specific set of supplies. Before opening the vial, gather the following:

  • Bacteriostatic water — 10mL or 30mL vial, 0.9% benzyl alcohol formulation
  • Insulin syringes — typically 1mL (100-unit) or 0.5mL (50-unit), 27- to 31-gauge
  • Alcohol prep pads — for sanitizing the rubber stoppers of both vials
  • Clean, flat work surface — preferably a benchtop wiped with 70% isopropyl
  • Nitrile gloves — to avoid contaminating the vial septum
  • Sharps container — for safe needle disposal post-procedure

Quality of supplies matters. Low-grade bacteriostatic water with inconsistent benzyl alcohol concentration can shorten the stability window of your reconstituted solution. Sourcing both the peptide and the diluent from suppliers that publish a per-lot Certificate of Analysis is the simplest way to control that variable.

How to Reconstitute Peptides Step-by-Step

Here is the exact procedure. Read it through once before starting so you don’t have to pause mid-process.

Step 1 — Bring the vial to room temperature. If you stored the lyophilized peptide in a freezer or refrigerator, let it sit on the bench for 20 to 30 minutes. Cold glass causes condensation when you open it, and moisture is the enemy of dry peptide stability.

Step 2 — Sanitize the stoppers. Wipe the rubber septum of both the bacteriostatic water vial and the peptide vial with a fresh alcohol prep pad. Let them air-dry for 15 to 20 seconds. Do not touch the cleaned surface afterward.

Step 3 — Draw the diluent. Insert your insulin syringe into the bacteriostatic water vial at a 90-degree angle. Pull back the plunger and draw your calculated volume (we’ll cover the math in the next section).

Step 4 — Inject down the side of the peptide vial. This is the critical move that most beginners get wrong. Do not aim the stream of water directly at the lyophilized powder. The force of the liquid hitting the cake can shear the peptide molecules and degrade the compound. Instead, tilt the vial slightly and let the bacteriostatic water trickle down the glass wall, pooling at the bottom around the powder.

Step 5 — Let it dissolve passively. Set the vial down upright and wait 30 to 60 seconds. Most peptides dissolve on their own as the water saturates the cake. If powder remains, swirl gently — never shake. Vigorous shaking introduces air bubbles and can denature the molecule. Some researchers prefer to roll the vial slowly between their palms for 20 to 30 seconds.

Step 6 — Inspect the solution. A correctly reconstituted peptide solution should be completely clear, with no cloudiness, particles, or precipitate. If you see anything floating, the compound may have been degraded — set the vial aside and document the lot number for follow-up.

Step 7 — Label the vial. Write the reconstitution date, the concentration (mg/mL), and the lot number on the vial or on a small label. This becomes critical for stability tracking across multiple experiments.

how to reconstitute peptides

How to Mix Peptides With Bacteriostatic Water: The Math

Choosing the right volume of bacteriostatic water is what determines your final concentration — and your dosing accuracy downstream. The formula is straightforward:

Concentration (mg/mL) = Peptide mass (mg) ÷ Volume of bacteriostatic water (mL)

For a 5mg peptide vial reconstituted with 2mL of bacteriostatic water:

  • Concentration = 5 ÷ 2 = 2.5 mg/mL

To convert into convenient measurement on a U-100 insulin syringe (where 100 units = 1mL):

  • Each 10 units on the syringe = 0.1mL = 0.25mg of peptide

Common reconstitution ratios used in research workflows:

Vial SizeBAC WaterConcentration10 units (U-100)
5mg1mL5.0 mg/mL0.50mg
5mg2mL2.5 mg/mL0.25mg
5mg2.5mL2.0 mg/mL0.20mg
10mg2mL5.0 mg/mL0.50mg
10mg3mL3.33 mg/mL0.33mg
15mg3mL5.0 mg/mL0.50mg

Higher concentrations (less water) save on syringe volume per dose but reduce the margin for measurement error. Most research protocols favor a 2.5 to 5 mg/mL working range as a balance between precision and shelf efficiency.

How to Reconstitute Lyophilized Peptides Without Damaging Them

The lyophilized form is structurally fragile. A few additional precautions protect the active compound during the rehydration step:

  • Never use hot water. Some researchers assume warm water dissolves powder faster — it doesn’t, and elevated temperatures can break the peptide bonds. Room-temperature bacteriostatic water is always correct.
  • Avoid pH extremes. Standard bacteriostatic water is buffered near neutral pH. Substituting acidic or alkaline solvents without protocol justification can hydrolyze sensitive sequences.
  • Don’t centrifuge unless required. Centrifugation isn’t needed for routine reconstitution and can stress certain delta-bonded sequences.
  • Reconstitute the entire vial at once. Partial reconstitution (adding a small amount of water and using the rest later) introduces moisture into a vial that’s supposed to stay dry. Once you open the vial for reconstitution, plan to use it on a stability schedule.

Storage of BPC-157, TB-500, and copper-bound sequences like GHK-Cu each have minor variations on these guidelines — but the core principle (room-temperature BAC water, side-of-vial delivery, gentle swirling) applies across the catalog.

How to Mix Bacteriostatic Water With Peptides for Long-Term Storage

Once a peptide is in solution, its stability clock starts. Bacteriostatic water’s benzyl alcohol gives you a window — but that window depends on temperature and the specific compound.

Refrigerated (2–8°C): Most peptides remain stable for 21 to 28 days once reconstituted. This is the standard storage condition for an actively-used research solution.

Frozen (-20°C): A reconstituted solution can be frozen for longer-term storage, but only freeze it once. Each freeze-thaw cycle degrades the molecule slightly, and after two or three cycles you’ll see meaningful loss of activity. To work around this, many researchers aliquot the reconstituted solution into smaller vials at the time of mixing — that way each future experiment thaws only what’s needed.

Room temperature: Avoid this for reconstituted peptides. Even with bacteriostatic water’s preservative, ambient temperature accelerates degradation significantly.

For deeper reading on peptide stability across storage conditions, the PubMed literature on peptide stability and the USP guidelines on bacteriostatic preparations are the primary references our lab uses internally.

how to reconstitute peptides

Common Reconstitution Mistakes

Most failed reconstitutions trace back to one of five issues. Watch for these:

  1. Shaking instead of swirling — produces foam, denatures the peptide, and shortens stability
  2. Spraying water directly onto the powder — high-velocity impact damages the lyophilized cake
  3. Reusing needles between vials — cross-contaminates the bacteriostatic water vial, killing the preservative
  4. Skipping the alcohol wipe — the rubber septum is not sterile out of the box; coring through unsanitized rubber introduces contaminants
  5. Failing to label — losing track of reconstitution date is the single most common reason researchers throw out expensive compounds

FAQ

Can I use sterile water instead of bacteriostatic water?

Yes, but the reconstituted solution must then be used within 24 hours. Sterile water has no preservative, so microbial growth becomes a risk after that window.

What if my peptide doesn’t fully dissolve?

Wait another 60 to 90 seconds and swirl gently again. If powder persists after five minutes of patient swirling, the cake may be over-compressed — gentle warming of the vial between your palms can help. Cloudy solutions or visible particles after that point indicate the vial may be compromised.

How long do peptides last once reconstituted?

With bacteriostatic water at 2–8°C, most research peptides remain stable for 21 to 28 days. Frozen at -20°C they can last several months, but only if frozen once.

Can I mix two peptides in the same vial?

Avoid this for routine research. Different sequences have different optimal storage conditions, and combined solutions complicate stability tracking. Use separate vials and combine in the syringe at the point of use only if a protocol requires it.

What size syringe should I use?

A U-100 (1mL) or U-50 (0.5mL) insulin syringe with a 27- to 31-gauge needle is standard. The fine gauge minimizes coring of the rubber septum across repeated draws.

For research-grade peptides with per-lot Certificates of Analysis and full HPLC-MS purity documentation, browse the OPS Peptide Science catalog or verify a specific lot using its COA code.

Author: Shane Straight, Principal Chemist, OPS Peptide Science
Reviewed: May 2026

Healing & Recovery, Peptide Education, Research Protocols

Peptides for Healing & Recovery: Complete Research Guide

Posted on by admin
Peptides for Healing
12
May

Research Use Only Notice: The compounds discussed in this guide are research peptides intended for in-vitro and animal research applications only. Nothing here constitutes medical advice, therapeutic recommendation, or guidance for human use. All peptides should be handled in accordance with research-use-only protocols.

Peptides for healing represent one of the most actively studied categories in modern research-compound science. Across animal and in-vitro models, a small group of peptide sequences has produced enough literature on tissue repair, anti-inflammatory effects, and recovery markers to anchor a distinct research subfield. This guide from the chemistry team at OPS Peptide Science walks through the four most-studied healing peptides — BPC-157, TB-500, GHK-Cu, and Thymosin Alpha-1 — including their proposed mechanisms, typical research applications, and what the published research literature actually documents.

If you’re new to the practical side of peptide research, the companion guides on how to reconstitute peptides, how to inject peptides, and peptide storage and refrigeration cover the laboratory protocols that underpin any of the research below.

What Makes a Peptide “Healing” in Research?

The category “healing peptides” isn’t a chemical classification — it’s a functional grouping based on the research applications a compound is most commonly studied for. The peptides covered in this guide share four characteristics in the published research:

  • Documented effects on tissue repair — measurable outcomes in animal injury models (tendon, muscle, gastrointestinal, skin)
  • Anti-inflammatory marker reduction — modulation of cytokines and inflammatory pathways in research
  • Angiogenesis-related activity — promotion of new blood vessel formation in research models
  • Cellular signaling effects — activation of growth factor pathways and repair-related transcription factors

None of these are FDA-approved drugs. All operate within the research-chemical pathway with research-use-only labeling. The science on each is at varying stages — some have decades of published animal research; others have only recently entered systematic study. None has completed the full FDA approval process required for human therapeutic use.

The broader peptide research literature documenting these compounds is available through the tissue-repair peptide research on PubMed, which is the authoritative source for primary studies.

Peptides for Healing

BPC-157 — Body Protection Compound

BPC-157 (Body Protection Compound-157) is a 15-amino-acid synthetic peptide derived from a sequence originally identified in gastric juice. It is one of the most extensively studied healing peptides in animal research literature, with hundreds of published studies covering gastrointestinal, musculoskeletal, and tissue-repair applications.

Research applications documented in literature:

  • Tendon and ligament repair in rodent injury models
  • Gastrointestinal mucosa healing in ulcer models
  • Vascular endothelial growth factor (VEGF) modulation
  • Nitric oxide system interactions
  • Anti-inflammatory effects across multiple tissue types

Proposed mechanism: BPC-157 appears to act through multiple pathways including the nitric oxide system, growth hormone receptor expression upregulation, and VEGF-mediated angiogenesis. The mechanism is not fully characterized — published research describes effects on several pathways without a single unified mechanism of action.

Research administration: Standard research protocols use subcutaneous injection of reconstituted BPC-157 in animal models. Dose ranges vary widely across the literature; specific protocol selection depends on the research model and outcome being measured.

Regulatory status: Not FDA-approved for human use. Removed from FDA 503A compounding lists in 2023. Added to the WADA Prohibited List in 2023 under category S0. Available legally as a research chemical with research-use-only labeling.

TB-500 (Thymosin Beta-4) — Tissue Repair Compound

TB-500 is the synthetic version of thymosin beta-4, a naturally occurring peptide found across many human tissues. Research focuses on its role in actin sequestration, cell migration, and tissue repair processes — particularly in cardiac, dermal, and corneal injury models.

Research applications documented:

  • Cardiac tissue repair in animal infarct models
  • Corneal wound healing studies
  • Dermal wound healing and scar tissue modulation
  • Hair follicle stem cell activation in research models
  • Anti-inflammatory effects through actin-related pathways

Proposed mechanism: Thymosin beta-4 binds G-actin and regulates actin polymerization, which is fundamental to cell migration during tissue repair. It also modulates inflammation through actin-independent pathways. The mechanism is better characterized than BPC-157’s but still involves multiple downstream effects.

Research administration: Subcutaneous or intramuscular injection in research models. Half-life is longer than many comparable peptides because of tissue binding, which influences dosing frequency in study designs.

Regulatory status: Not FDA-approved. WADA prohibited substance, banned in and out of athletic competition. Available legally as a research chemical with research-use-only labeling.

Peptides for Healing

GHK-Cu — Copper-Binding Tripeptide

GHK-Cu is a tripeptide (glycyl-L-histidyl-L-lysine) bound to a copper ion. It occurs naturally in human plasma and declines with age — a feature that has driven significant research interest in its applications for tissue repair, skin biology, and gene expression modulation.

Research applications documented:

  • Wound healing in dermal injury research models
  • Collagen synthesis upregulation
  • Hair follicle research
  • Antioxidant effects through copper-related enzyme systems
  • Gene expression modulation — published research documents effects on hundreds of genes related to repair and regeneration

Proposed mechanism: GHK-Cu acts through multiple copper-dependent enzyme systems and direct effects on gene expression. The copper coordination is functionally important — uncomplexed GHK has different activity than GHK-Cu. Research has documented modulation of fibroblast activity, collagen synthesis pathways, and stem cell-related markers.

Research administration: Topical formulations dominate the published research; injectable research formulations are less common. Topical research formulations have been incorporated into cosmetic products legally as cosmetic ingredients (not as drugs).

Regulatory status: Cosmetic-grade GHK-Cu is permitted in skincare products. Research-grade GHK-Cu for systemic study is sold under research-use-only labeling. Not FDA-approved for systemic therapeutic use.

Thymosin Alpha-1 — Immune Modulator

Thymosin Alpha-1 is a 28-amino-acid peptide derived from the thymus gland — the organ that orchestrates T-cell maturation. Research interest spans immune modulation, infectious disease models, and recovery from immunosuppression.

Research applications documented:

  • T-cell function modulation in immune research models
  • Hepatitis B and C research as an immune modulator (approved for therapeutic use in some countries)
  • Sepsis and severe infection research
  • Immune recovery following immunosuppression
  • Vaccine adjuvant research

Proposed mechanism: Thymosin Alpha-1 modulates T-cell maturation, dendritic cell function, and toll-like receptor signaling. The mechanism is among the most studied of the peptides in this guide, with a substantial clinical literature in countries where it is therapeutically approved.

Research administration: Subcutaneous injection in research models, with twice-weekly or daily dosing common in published protocols. The peptide is relatively well-characterized pharmacokinetically.

Regulatory status: Approved for therapeutic use in over 35 countries internationally for hepatitis and immune indications, but not FDA-approved in the United States. Available as a research chemical with research-use-only labeling for US research.

How Healing Peptides Are Studied in Research Models

Research methodology for healing peptides follows the same patterns used for other compound classes in pre-clinical study:

  • In-vitro cell culture studies — measuring effects on fibroblast proliferation, collagen synthesis, inflammatory marker secretion, and cell migration
  • Animal injury models — typically rodents, with controlled injuries to tendons, gastrointestinal mucosa, skin, or cardiac tissue, followed by peptide administration and outcome measurement
  • Histological analysis — tissue samples examined microscopically to characterize repair patterns at the cellular level
  • Biomarker measurement — circulating markers of inflammation, growth factors, and tissue-specific proteins quantified across timepoints
  • Functional outcome assessment — measurable functional recovery in injury models (grip strength after muscle injury, healing time in wound models, etc.)

The published animal-model peptide research on NCBI/PMC represents the body of evidence for each compound discussed in this guide.

BPC-157 + TB-500 Combination Research

Combined BPC-157 and TB-500 protocols appear frequently in research literature — the rationale being that the two peptides act through different mechanisms (angiogenesis/VEGF for BPC-157, actin-cell migration for TB-500) and may produce additive effects on tissue repair outcomes.

Research design considerations for combination studies:

  • Separate reconstitution and injection — combining solutions before administration alters stability for both peptides
  • Alternating injection sites to maintain accurate dosing tracking
  • Documenting administration of each compound separately in the research log
  • Measuring endpoints over a timeline that captures the differing half-lives of each peptide

Whether the combined effect is genuinely additive or synergistic remains an active research question — the literature documents both individual and combined protocols without yet establishing definitive comparative effect sizes.

Peptides for Healing

FAQ

What are the best peptides for healing in research?

The four most-studied research peptides for tissue-repair applications are BPC-157, TB-500, GHK-Cu, and Thymosin Alpha-1. Each acts through different proposed mechanisms and is studied in different research models — there is no single “best” peptide across all healing research questions.

Are healing peptides FDA-approved?

No. None of the peptides covered in this guide are FDA-approved for therapeutic human use. They are sold legally in the United States as research chemicals with research-use-only labeling, and are not intended for human consumption or therapeutic application.

How long do healing peptides take to work in research models?

Research timelines vary by peptide and endpoint. Acute anti-inflammatory effects often appear within days; tissue-level repair endpoints typically require 2–4 weeks of consistent dosing in animal models. Specific timelines for each peptide are documented in the published research literature.

Can BPC-157 and TB-500 be combined in research?

Combination protocols appear in published animal research. The rationale is that the two peptides act through different mechanisms and may produce additive tissue-repair effects. Research design requires separate reconstitution, alternating administration sites, and careful endpoint timing to characterize each compound’s contribution.

Are healing peptides legal to buy in the US?

Yes, research-grade healing peptides are legally sold in the United States under research-use-only labeling. They are not legally sold or prescribed for human consumption. Our companion guide on are peptides illegal covers the full legal framework in detail.

Healing peptides remain one of the most active research-compound categories, with documented effects spanning multiple mechanisms and tissue types. BPC-157, TB-500, GHK-Cu, and Thymosin Alpha-1 each contribute different research applications — and the published literature continues to expand the picture of how these compounds modulate the repair processes that underpin recovery from tissue injury.

For research-grade healing peptides backed by per-lot Certificates of Analysis and full HPLC-MS purity documentation, browse the OPS Peptide Science catalog, visit the OPS Peptide Science homepage for the full product overview, or verify a specific lot using its COA code.

Author: Shane Straight, Principal Chemist, OPS Peptide Science
Reviewed: May 2026

Hello!

Click one of our representatives below to chat on Telegram or send us an email to sales@opsscience.org

Powered by OPS

Contact Us On Telegram